Cargando…
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Ischemic heart disease (IHD) is the leading cause of death and disability worldwide. Therefore, novel therapeutic targets for protecting the heart against acute ischemia/reperfusion injury (IRI) are required to attenuate cardiomyocyte death, preserve myocardial function, and prevent the onset of hea...
Autores principales: | Mukherjee, Uma A., Ong, Sang-Bing, Ong, Sang-Ging, Hausenloy, Derek J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667215/ https://www.ncbi.nlm.nih.gov/pubmed/26481155 http://dx.doi.org/10.1016/j.pharmthera.2015.10.005 |
Ejemplares similares
-
Mitochondrial-Shaping Proteins in Cardiac Health and Disease – the Long and the Short of It!
por: Ong, Sang-Bing, et al.
Publicado: (2017) -
Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease
por: Ong, Sang-Bing, et al.
Publicado: (2015) -
Targeting mitochondrial fusion and fission proteins for cardioprotection
por: Hernandez‐Resendiz, Sauri, et al.
Publicado: (2020) -
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning
por: Hausenloy, Derek J., et al.
Publicado: (2010) -
Nuclear translocation of mitochondrial dehydrogenases as an adaptive cardioprotective mechanism
por: Srivastava, Shubhi, et al.
Publicado: (2023)